About Breast Cancer

Breast Cancer in Hispanic Women: Rates, Risks, & Resources

three generations of latina women sit on a bench
Aldomurillo/iStock

How health disparities in breast cancer affect the Hispanic/Latin American communities

Breast cancer is the most common cancer among U.S. women, and is the second-leading cause of cancer deaths among this group, according to the American Cancer Society. While there has been more than a 40% decline in breast cancer deaths over the last 30 years, thanks to progress in awareness, early diagnosis, and treatment, there is a persistent mortality gap between racial groups in the U.S.

Hispanic or Latino refers to individuals born in Latin America or whose ancestors were born there and have continental ancestry. Until recently, the diversity within this population had not been systematically addressed in cancer research. The lack of data breaking down subgroups of Hispanics and Latinos has resulted in these individuals of varied racial backgrounds being considered as one category.

Key takeaways

  • Although Hispanic women have a 25% lower overall incidence than non-Hispanic white women, breast cancer remains the leading cause of cancer death among Latinas.
  • Approximately 1 in 9 Hispanic women will be diagnosed with breast cancer in her lifetime, with U.S. incidence rates rising by 1.6% annually.
  • Latinas are disproportionately diagnosed at younger ages, at later stages, and with more aggressive forms such as triple-negative breast cancer.
  • Lower rates of BRCA mutation testing, delayed screening mammograms, and social determinants of health contribute significantly to the mortality gap
  • Adopting healthy lifestyle habits, staying current with routine screenings, and expanding diversity in clinical trials are essential to improving outcomes for Hispanic women.

Breast cancer in Hispanic women: Understanding the disparities

Hispanic women and Latinas are not homogeneous, and the risk of developing breast cancer among these women varies by national origin and genetic ancestry.

While breast cancer incidence in the overall group is lower than in non-Hispanic white women, it is still the leading cause of cancer deaths in these populations, as in all women. Although Latin America is genetically diverse, Hispanic women and Latinas are more likely to be diagnosed at a younger age and with more aggressive disease, such as triple-negative breast cancer, which has fewer targeted treatments. They also tend to be diagnosed at more advanced stages.

Many complex and interconnected factors contribute to racial disparities in breast cancer development and outcomes. These factors include genetics, lifestyle, access to healthcare, social determinants of health, and limited research conducted in people of color. Data make clear that advances in treatment that have dramatically reduced breast cancer mortality have not equally benefited all groups.

What is the breast cancer rate for Hispanic women?

When looking at the breast cancer rate in Hispanic women, the statistics tell a complex story. In the U.S., the overall incidence is about 25% lower than in non-Hispanic white women.

However, the trends are concerning. Data from the American Cancer Society shows that breast cancer incidence increased in Hispanic women by 1.6% annually from 2012 through 2021. While overall risk is lower, 1 in 9 Hispanic women will be diagnosed with breast cancer in her lifetime.

Breast Cancer Glossary

Mentioned in this article:

Why are Hispanic women and Latinas diagnosed at later stages?

Hispanics and Latin Americans are less likely to receive genetic screening for BRCA mutations compared to other populations worldwide. Studies thus far, however, find that women in many regions of Latin America have higher BRCA mutation incidence with specific mutations frequently seen in the population, as well as differences in how their breast cancer behaves. To date, research has found no difference in treatment response rates between Hispanic women and Latinas and other ethnic groups.

Social determinants also significantly influence overall health by affecting nearly every aspect of care, including access to insurance, preventive care, and treatment. Hispanic women and Latinas are disproportionately affected by these factors, which is reflected in the lower rates of screening mammograms among this group.

Regular screening mammograms are considered to be one of the most reliable methods to detect breast cancer in its early stages. While breast cancer screening has increased across all racial and ethnic groups, Hispanic women and Latinas are still less likely to be diagnosed with early-stage breast cancer, partially due to infrequent mammograms or a lack of follow-up on abnormal screening results. This delay results in more advanced breast cancer at the time of diagnosis. Explanations for lapsed mammography could include inadequate health insurance coverage, limited access to care, lack of knowledge of the healthcare system, or language barriers.

Research on breast cancer in Hispanic women and latinas

The Breast Cancer Research Foundation (BCRF) recognizes the ongoing need for research to eliminate disparities and improve outcomes for all by fostering innovative, collaborative science. BCRF investigators are working to understand the differences in breast cancer biology across racial and ethnic groups and are making strides to reduce the risk of breast cancer for all women.

While we have made significant progress in understanding the drivers of breast cancer, most studies and clinical trials are in non-Hispanic white women. Increasing participation of underrepresented groups provides an opportunity to gain valuable insights into tumor biology and its variations among all people. This will ultimately enable the development of more personalized therapies and improve outcomes for Hispanic women and Latinas diagnosed with breast cancer.

Steps to lower your breast cancer risk

Lifestyle can play a critical role in breast cancer prevention. Hispanic women and Latinas in the U.S. have a higher incidence of breast cancer than their counterparts living in Latin America, most likely due to lifestyle changes.

Diets rich in vegetables, fruits, whole grains, and low in red meat and alcohol, like the traditional diets of many ethnic groups in Latin America, have consistently been associated with a decreased risk of breast cancer. Consuming a more American diet by choice or because of lack of access to fresh foods, and associated weight gain, may be a part of the reason for this discrepancy in breast cancer risk among Hispanic women and Latinas, particularly after menopause.

Help us close the disparity gap in breast cancer

BCRF investigators are working to understand the differences in breast cancer biology across racial and ethnic groups and are making strides to reduce the risk of breast cancer for all women.

FAQs

Q: What is the breast cancer rate in Hispanic women?

A: While Hispanic women have a roughly 20% lower overall incidence of breast cancer than the general population, the rate is rising. Breast cancer incidence increased in Hispanic women by 1.6% annually from 2012 through 2021 vs. 1.1% annually in white women.

Q: Are Hispanic women more likely to get breast cancer?

A: Overall incidence is lower, but breast cancer remains the leading cause of cancer death among Hispanic women. This is largely because they are often diagnosed at later, more advanced stages and are more susceptible to aggressive forms like triple-negative breast cancer.

Q: How do BRCA gene mutations affect Hispanic women?

A: Research shows women in many regions of Latin America have a high frequency of BRCA mutations, yet they are less likely to receive genetic screening for them compared to other populations.

Medical Statement

Information and articles in BCRF’s “About Breast Cancer” resources section are for educational purposes only and are not intended as medical advice. Content in this section should never replace conversations with your medical team about your personal risk, diagnosis, treatment, and prognosis. Always speak to your doctor about your individual situation.

Editorial Team

BCRF’s “About Breast Cancer” resources and articles are developed and produced by a team of experts. Chief Scientific Officer Dorraya El-Ashry, PhD provides scientific and medical review. Scientific Directors, Research Program Priya Malhotra, PhD; Marisa Rubio, PhD; and Diana Schlamadinger, PhD research and write content with some additional support. Director of Content Emily Goldman serves as editor.

Breast Cancer Glossary

Discover
legacy-Society

Support research with a legacy gift. Sample, non-binding bequest language:

I give to the Breast Cancer Research Foundation, located in New York, NY, federal tax identification number 13-3727250, ________% of my total estate (or $_____).

Learn More